UPDATE 2-FDA declines to approve J&J arthritis drug sirukumab
September 22, 2017 at 17:19 PM EDT
Sept 22 (Reuters) - The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday.
